Onto Innovation Inc. — 2022 Form 10-K Summary
Period note: The request metadata says “2020 Q4,” but the supplied filing is Onto Innovation’s Form 10-K for the fiscal year ended December 31, 2022. The figures below summarize the filing actually provided. Fiscal 2021 ended January 1, 2022; fiscal 2020 ended December 26, 2020.
Business context
Onto designs, manufactures and supports semiconductor process-control equipment and software, including metrology, defect inspection and advanced-packaging lithography systems. Its customers include wafer manufacturers, semiconductor fabricators and advanced-packaging providers. The company reports one operating and reportable segment. Management said fiscal 2022 revenue reached $1 billion, driven by advanced-node transitions and higher advanced-packaging volumes.
Financial performance and liquidity
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Revenue | $1,005.2 million | $788.9 million | Up 27.4% |
| Gross profit | $539.2 million | $429.1 million | Up 25.7% |
| Gross margin | 53.6% | 54.4% | Down 0.8 percentage points |
| Operating income | $236.7 million | $156.4 million | Up 51.3% |
| Operating margin | 23.5% | 19.8% | Up 3.7 percentage points |
| Net income | $223.3 million | $142.3 million | Up 56.9% |
| Diluted EPS | $4.49 | $2.86 | Up 57.0% |
| Operating cash flow | $136.7 million | $175.3 million | Down 22.0% |
- Revenue mix: Systems and software contributed $865.7 million (86%); parts $84.3 million (8%); services $55.2 million (6%). Systems and software growth reflected stronger demand in advanced nodes, specialty devices and advanced packaging.
- Cash and liquidity: Cash, cash equivalents and marketable securities totaled $547.8 million at year-end, versus $511.3 million a year earlier. Working capital was $974.3 million, up from $793.6 million.
- Cash uses: Investing activities used $55.7 million, including $18.4 million of capital expenditures. Financing activities used $68.4 million, primarily including $65.3 million of share repurchases and $8.9 million of employee tax-withholding payments.
- Debt and credit: The filing reports no borrowings outstanding. The company had an unused, securities-backed credit line with approximately $108.4 million available at a stated 6.0% rate.
- Margins and expenses: Gross margin eased amid supply-chain cost increases and unfavorable product mix, partly offset by higher factory utilization. Operating expenses rose to $302.5 million from $272.7 million; operating expenses declined as a share of revenue.
- Customer and geographic concentration: Taiwan Semiconductor Manufacturing Co. represented 15% of revenue, Samsung Semiconductor 13%, and SK Hynix 11%. China was the largest reported revenue region at 25%, followed by South Korea at 22% and Taiwan at 20%.
Material changes and unusual items
- Revenue grew 27.4% in FY2022, following 41.8% growth in FY2021. Net income rose substantially, while operating cash flow fell from FY2021, in part because of increased accounts receivable and inventory.
- Inventory increased to $324.3 million from $243.1 million. The auditor identified the excess-and-obsolete-inventory reserve as a critical audit matter, citing judgment around demand, product life cycles and market conditions.
- Research and development expense included a $5.7 million write-off of acquired in-process research and development assets.
- The effective tax rate was 7.6%, versus 8.6% in FY2021. Management attributed the FY2022 rate chiefly to the Foreign-Derived Intangible Income deduction, research credits and stock-compensation tax benefits.
- The company repurchased 1.018 million shares for $65.3 million during FY2022. Approximately $34.8 million remained authorized at year-end. It has not declared or paid cash dividends.
- Marketable securities had $3.6 million of gross unrealized losses at year-end; management reported no impairment charge for goodwill or in-process research and development in the years presented.
Outlook, management commentary and risks
- Management expected weaker demand, particularly in memory and advanced nodes, and a reduction in wafer-fabrication-equipment spending in FY2023. It also cited regulatory conditions and a slowing economic environment as expected headwinds. The filing provides no specific overall FY2023 revenue or earnings guidance.
- Management estimated that October 2022 U.S. export controls would reduce FY2023 revenue by approximately $80 million. Licenses are required for certain China-related business; delays or denials could reduce sales, and affected inventory could incur carrying costs or charges.
- Supply constraints, long component lead times, inflation and logistics challenges had delayed some customer deliveries and were expected to persist into FY2023. Limited-source suppliers and purchase commitments are additional exposures.
- Other principal risks include semiconductor-industry cyclicality, concentrated customers, competition, lengthy sales cycles, product-development and acceptance risk, export restrictions and geopolitical tensions in Asia, cybersecurity, and potential customer order delays or cancellations.
- The company said COVID-19 had disrupted operations but had not materially adversely affected them to date. It reported effective disclosure controls and internal control over financial reporting; the independent auditor issued unqualified opinions on the financial statements and internal controls.
Important facts for investors to verify
- Track whether the anticipated $80 million FY2023 export-control revenue impact materialized and whether required licenses were obtained.
- Check subsequent results for the expected slowdown in wafer-fabrication-equipment spending, especially in memory and advanced nodes.
- Monitor inventory, receivables and operating cash flow: inventory rose materially while FY2022 operating cash flow declined.
- Assess customer concentration and exposure to China, Taiwan and South Korea, including the effect of export rules and geopolitical developments.
- Review subsequent disclosures for changes in inventory reserves, supplier constraints, purchase commitments, legal contingencies and the unused credit facility.